1 Ocak 2018 Dergi makalesi Açık Erişim

Sarikaya, Gorkem; Coban, Gunes; Parlar, Sulunay; Tarikogullari, Ayse H.; Armagan, Guliz; Erdogan, Mumin A.; Alptuzun, Vildan; Alpan, Ayse S.

MARC21 XML

<?xml version='1.0' encoding='UTF-8'?>
<record xmlns="http://www.loc.gov/MARC21/slim">
  <leader>00000nam##2200000uu#4500</leader>
  <datafield tag="245" ind1=" " ind2=" ">
    <subfield code="a">Multifunctional cholinesterase inhibitors for Alzheimer's disease: Synthesis, biological evaluations, and docking studies of o/p-propoxyphenylsubstituted-1H-benzimidazole derivatives</subfield>
  </datafield>
  <datafield tag="909" ind1="C" ind2="4">
    <subfield code="p">ARCHIV DER PHARMAZIE</subfield>
    <subfield code="v">351</subfield>
    <subfield code="n">8</subfield>
  </datafield>
  <controlfield tag="001">34745</controlfield>
  <datafield tag="980" ind1=" " ind2=" ">
    <subfield code="a">user-tubitak-destekli-proje-yayinlari</subfield>
  </datafield>
  <datafield tag="520" ind1=" " ind2=" ">
    <subfield code="a">This study indicates the synthesis, cholinesterase (ChE) inhibitory activity, and molecular modeling studies of 48 compounds as o- and p-(3-substitutedethoxyphenyl)-1H-benzimidazole derivatives. According to the ChE inhibitor activity results, generally, para series are more active against acetylcholinesterase (AChE) whereas ortho series are more active against butyrylcholinesterase (BuChE). The most active compounds against AChE and BuChE are compounds A12 and B14 with IC50 values of 0.14 and 0.22M, respectively. Additionally, the most active 16 compounds against AChE/BuChE were chosen to investigate the neuroprotective effects, and the results indicated that most of the compounds have free radical scavenging properties and show their effects by reducing free radical production; moreover, some of the compounds significantly increased the viability of SH-SY5Y cells exposed to H2O2. Overall, compounds A12 and B14 with potential AChE and BuChE inhibitory activities, high neuroprotection against H2O2-induced toxicity, free radical scavenging properties, and metal chelating abilities may be considered as lead molecules for the development of multi-target-directed ligands against Alzheimer's disease.</subfield>
  </datafield>
  <datafield tag="650" ind1="1" ind2="7">
    <subfield code="2">opendefinition.org</subfield>
    <subfield code="a">cc-by</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="u">Ege Univ, Dept Pharmaceut Chem, Fac Pharm, TR-35040 Izmir, Turkey</subfield>
    <subfield code="a">Coban, Gunes</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="u">Ege Univ, Dept Pharmaceut Chem, Fac Pharm, TR-35040 Izmir, Turkey</subfield>
    <subfield code="a">Parlar, Sulunay</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="u">Ege Univ, Dept Pharmaceut Chem, Fac Pharm, TR-35040 Izmir, Turkey</subfield>
    <subfield code="a">Tarikogullari, Ayse H.</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="u">Ege Univ, Dept Biochem, Fac Pharm, Izmir, Turkey</subfield>
    <subfield code="a">Armagan, Guliz</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="u">Izmir Katip Celebi Univ, Dept Physiol, Fac Med, Izmir, Turkey</subfield>
    <subfield code="a">Erdogan, Mumin A.</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="u">Ege Univ, Dept Pharmaceut Chem, Fac Pharm, TR-35040 Izmir, Turkey</subfield>
    <subfield code="a">Alptuzun, Vildan</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="u">Ege Univ, Dept Pharmaceut Chem, Fac Pharm, TR-35040 Izmir, Turkey</subfield>
    <subfield code="a">Alpan, Ayse S.</subfield>
  </datafield>
  <datafield tag="980" ind1=" " ind2=" ">
    <subfield code="b">article</subfield>
    <subfield code="a">publication</subfield>
  </datafield>
  <datafield tag="542" ind1=" " ind2=" ">
    <subfield code="l">open</subfield>
  </datafield>
  <datafield tag="100" ind1=" " ind2=" ">
    <subfield code="u">Ege Univ, Dept Pharmaceut Chem, Fac Pharm, TR-35040 Izmir, Turkey</subfield>
    <subfield code="a">Sarikaya, Gorkem</subfield>
  </datafield>
  <datafield tag="260" ind1=" " ind2=" ">
    <subfield code="c">2018-01-01</subfield>
  </datafield>
  <controlfield tag="005">20210315191322.0</controlfield>
  <datafield tag="909" ind1="C" ind2="O">
    <subfield code="o">oai:zenodo.org:34745</subfield>
    <subfield code="p">user-tubitak-destekli-proje-yayinlari</subfield>
  </datafield>
  <datafield tag="856" ind1="4" ind2=" ">
    <subfield code="z">md5:f7b1bf4bf6acd958b7e7e233f8d9d745</subfield>
    <subfield code="s">328</subfield>
    <subfield code="u">https://aperta.ulakbim.gov.trrecord/34745/files/bib-c32ddedf-cb5f-4180-b5ca-f97bebf9cd5a.txt</subfield>
  </datafield>
  <datafield tag="540" ind1=" " ind2=" ">
    <subfield code="u">http://www.opendefinition.org/licenses/cc-by</subfield>
    <subfield code="a">Creative Commons Attribution</subfield>
  </datafield>
  <datafield tag="024" ind1=" " ind2=" ">
    <subfield code="a">10.1002/ardp.201800076</subfield>
    <subfield code="2">doi</subfield>
  </datafield>
</record>